Stock page
Rokit America Inc (RKAM)
Rokit America Inc develops and markets Reverse-Aging Products (RAP) through e-commerce and distribution channels. The company's operations focus on research, development, and commercialization of dietary bio-supplements, including its flagship ROKIT AMERICA NMN line, designed to support cellular health. It also operates under a licensing agreement to develop and commercialize regenerative medicine technologies, including organ regeneration platform products, which it sells in the Americas. The majority of the company's revenue is derived from the sales of dietary supplement products either under the company's brands or private-label through wholesale distributors and e-commerce platforms. Geographically, it generates the maximum revenue from Korea.
Quote snapshot
Price chart
Price history
| Name |
|---|
| Revenue |
| Cost Of Goods Sold |
| Gross Profit |
| Gross Margin % |
| Research Development |
| Selling General Admin Expense |
| Depreciation Depletion Amortization |
| Other Operating Expense |
| Total Operating Expense |
| Operating Income |
| Operating Margin |
| Interest Income |
| Interest Expense |
| Other Income Expense |
| Other Income Minority Interest |
| Other Net Income Loss |
| Ebit |
| Ebitda |
| Ebitda Margin |
| Pretax Income |
| Tax Provision |
| Tax Rate |
| Net Income Continuing Operations |
| Net Income Discontinued Operations |
| Net Income |
| Net Income Including Noncontrolling Interests |
| Is Preferred Dividends |
| Shares Outstanding |
| Eps Basic |
| Eps Diluted |
| Net Margin |
SEC filings
Latest 10-K filing table
| Date | Form | Accession | Link |
|---|